We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

45 hedge funds and large institutions have $37.2M invested in Ampio Pharmaceuticals Inc. in 2013 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less call options, than puts

Call options by funds: $379K | Put options by funds: $387K

Holders
45
Holders Change
+45
Holders Change %
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
45
Increased
Reduced
Closed
Calls
$379K
Puts
$387K
Net Calls
-$8K
Net Calls Change
-$8K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

AMPE Hedge Fund Activity: Q2 2013 in Review

45 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2013, worth a combined $37.2M.

Buyers outnumbered sellers: 45 funds opened new AMPE positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

  • 45 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $37.2M of Ampio Pharmaceuticals Inc. stock for Q2 2013.
  • 45 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2013 and 0 closed out, a net change of +45 holders.

Based on aggregated 13F filings for Q2 2013.